Guideline of the diagnosis and treatment of eosinophilic disorders (2024)
10.3760/cma.j.cn121090-20231222-00334
- VernacularTitle:中国嗜酸性粒细胞增多症诊断和治疗指南（2024版）
- Keywords:
Eosinophilia;
Diagnosis;
Treatment;
Guideline
- From:
Chinese Journal of Hematology
2024;45(1):1-7
- CountryChina
- Language:Chinese
-
Abstract:
The eosinophilias encompass a broad range of nonhematologic (secondary or reactive) and hematologic (primary or clonal) disorders with potential for end-organ damage. Based on new clinical data and increased understanding of disease molecular genetics, the World Health Organization (WHO) and the international consensus classification (ICC) has provided updated criteria and classifications for eosinophilic disorders in 2022. This guideline represents an update of Chinese expert consensus on the diagnosis and treatment of eosinophilia published in 2017 and aim to provide Chinese hematologist with clear guidance on management for eosinophilic disorders.
